Cellectis S.A.
CLLS- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001627281
No open-market purchases or sales by Cellectis S.A. insiders were filed in the last 90 days; 27 institutions reported holding it in 13F filings for Q2 2026, worth $28.4M in total; no superinvestor holds it.
13F holders, Q1 2024
Institutional positions in Cellectis S.A. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 31
- −2 vs. Q4 2023
- Shares held
- 9.85M
- +38.2K (+0.4%) vs. Q4 2023
- Total value
- $26.1M
- −$4.12M (−13.6%) vs. Q4 2023
- New holders
- 3
- 9 more added
- Sold out
- 5
- 5 more reduced
1 institution that held it in Q4 2023 haven't filed for Q1 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CLLS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 27 | $28.4M |
| Q1 2026 | 32 | $32.5M |
| Q4 2025 | 34 | $51.1M |
| Q3 2025 | 28 | $23.7M |
| Q2 2025 | 24 | $17.9M |
| Q1 2025 | 27 | $16.9M |
| Q4 2024 | 29 | $23.0M |
| Q3 2024 | 27 | $20.9M |
| Q2 2024 | 27 | $18.3M |
| Q1 2024 | 31 | $26.1M |
| Q4 2023 | 34 | $30.2M |
| Q3 2023 | 31 | $18.1M |
| Q2 2023 | 36 | $27.6M |
| Q1 2023 | 34 | $29.3M |
| Q4 2022 | 40 | $18.3M |
| Q3 2022 | 50 | $23.6M |
| Q2 2022 | 45 | $30.6M |
| Q1 2022 | 51 | $55.8M |
| Q4 2021 | 57 | $123.7M |
| Q3 2021 | 70 | $194.1M |
| Q2 2021 | 78 | $250.6M |
| Q1 2021 | 81 | $308.0M |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding Cellectis S.A.; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Sofos Investments, Inc. | 1 | $3 | 0.00% | −9−90.0% | Reduced |
| EverSource Wealth Advisors, LLC | 13 | $33 | 0.00% | 00.0% | Unchanged |
| Toronto Dominion Bank | 31 | $82 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 36 | $95 | 0.00% | +34+1,700.0% | Added |
| FRG Family Wealth Advisors LLC | 80 | $205 | 0.00% | +80 | New |
| JPMorgan Chase & Co | 83 | $220 | 0.00% | 00.0% | Unchanged |
| Old Point Trust & Financial Services N A | 250 | $663 | 0.00% | +250 | New |
| Qube Research & Technologies Ltd | 312 | $827 | 0.00% | −4,165−93.0% | Reduced |
| POM Investment Strategies, LLC | 495 | $1.31K | 0.00% | 00.0% | Unchanged |
| Allworth Financial LP | 500 | $1.32K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 1,080 | $2.86K | 0.00% | −3,500−76.4% | Reduced |
| Group One Trading, L.P. | 1,523 | $4.04K | 0.00% | +1,193+361.5% | Added |
| BlackRock Inc. | 2,755 | $7.30K | 0.00% | 00.0% | Unchanged |
| Rhumbline Advisers | 3,855 | $10.2K | 0.00% | 00.0% | Unchanged |
| National Bank of Canada | 3,600 | $10.8K | 0.00% | 00.0% | Unchanged |
| Harbour Investments, Inc. | 6,100 | $16.2K | 0.00% | +6,100 | New |
| Geode Capital Management, LLC | 10,776 | $28.6K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 12,940 | $34.3K | 0.00% | −1,354−9.5% | Reduced |
| BNP Paribas Arbitrage, SA | 16,800 | $44.5K | 0.00% | +1,000+6.3% | Added |
| Susquehanna International Group, LLP | 27,655 | $73.3K | 0.00% | +8,131+41.6% | Added |
| Two Sigma Investments, LP | 49,880 | $132.2K | 0.00% | −2,367−4.5% | Reduced |
| LPL Financial LLC | 81,347 | $215.6K | 0.00% | +9,160+12.7% | Added |
| Morgan Stanley | 84,145 | $223.0K | 0.00% | +7,920+10.4% | Added |
| Oppenheimer & Co Inc | 133,890 | $354.8K | 0.01% | +747+0.6% | Added |
| KBC Group NV | 163,447 | $433.0K | 0.00% | 00.0% | Unchanged |
| Macquarie Group Ltd | 226,875 | $601.0K | 0.00% | 00.0% | Unchanged |
| Principal Financial Group Inc | 424,533 | $1.13M | 0.00% | +24,906+6.2% | Added |
| Baillie Gifford & Co | 827,248 | $2.19M | 0.00% | +10,605+1.3% | Added |
| Credit Suisse AG | 1,438,255 | $3.81M | 0.00% | 00.0% | Unchanged |
| Capital International Investors | 1,848,804 | $4.90M | 0.00% | 00.0% | Unchanged |
| Long Focus Capital Management, LLC | 4,487,293 | $11.9M | 1.37% | 00.0% | Unchanged |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −17,784−100.0% | Sold out |
| Tennessee Valley Asset Management Partners | 0 | $0 | 0.00% | −2,430−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| FMR LLC | 0 | $0 | 0.00% | −40−100.0% | Sold out |
| Cutler Group LP | 0 | $0 | 0.00% | −200−100.0% | Sold out |
| Baystate Wealth Management LLC | – | – | – | – | Not filed |